Actinium Pharmaceuticals Inc (ATNM)

6.350
-0.450(-6.62%)
After Hours
6.350
0.000(0.00%)
- Real-time Data
  • Volume:
    235,047
  • Bid/Ask:
    6.200/6.490
  • Day's Range:
    6.100 - 6.690

ATNM Overview

Prev. Close
6.8
Day's Range
6.1-6.69
Revenue
1.12M
Open
6.68
52 wk Range
5.7-11.9
EPS
-1.24
Volume
235,047
Market Cap
139.9M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
222,535
P/E Ratio
-
Beta
0.59
1-Year Change
-41.42%
Shares Outstanding
22,030,838
Next Earnings Date
18 Mar 2022
What is your sentiment on Actinium Pharmaceuticals Inc?
or
Market is currently closed. Voting is open during market hours.

Actinium Pharmaceuticals Inc Company Profile

Employees
32

Actinium Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly relapsed or refractory acute myeloid leukemia trial for BMT conditioning; and a Phase I study with a CD19 CAR T-cell therapy with memorial sloan kettering cancer center. The company is also developing a multi-disease, multi-target pipeline of clinical-stage antibody radiation-conjugates targeting the antigens CD45 and CD33 for targeted conditioning and as a therapeutic either in combination with other therapeutic modalities or as a single agent for patients with a range of hematologic malignancies, including acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma. Actinium Pharmaceuticals, Inc. has research collaboration with Astellas Pharma, Inc. to develop targeted radiotherapies using its Antibody Warhead Enabling technology platforms. The company was founded in 2000 and is based in New York, New York.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsSellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.